How long does the first dose of Wegovy take to work?

The myth: the first dose should work quickly

A very common expectation, and an understandable one, is that the first injection of Wegovy should trigger rapid weight loss within days. It does not, and the reason is built into how the medicine is designed. Semaglutide is a GLP-1 receptor agonist: it mimics a gut hormone that regulates appetite, slows the rate at which food leaves the stomach, and signals fullness. Those effects are real, but they operate gradually, and the prescribing schedule reflects that biology.

The starting dose (0.25 mg weekly) exists specifically to let your body adapt. Most of the side effects people worry about (nausea, digestive discomfort, that heavy post-meal feeling) peak at the beginning of treatment, so the schedule is built to keep them manageable. Expecting weight loss at this stage is like expecting a car to reach motorway speed before the engine has warmed up. The first injection is the beginning of a process, not a single event.

The NHS medicines guidance for semaglutide describes the standard dose escalation and what to expect at each stage, and it is the right starting point if you want to understand the medicine at a clinical level.

When changes typically start — and what kind of changes to expect first

The experience that tends to arrive earliest is not the number on the scales moving: it is a quieter internal shift. Many people report that familiar food urges feel less insistent somewhere in the first fortnight. You may finish a meal and feel satisfied sooner than usual. You might notice that snacking between meals simply stops occurring to you. These are early signals that the medicine is beginning to do what it is licensed to do, even before meaningful body weight has shifted.

In pharmacokinetic terms, semaglutide reaches a stable concentration in the body (known as steady state) after approximately four to five weeks of weekly dosing. Before that point the medicine is still accumulating. So while week one or two can produce subtle changes in appetite, the full effect of even the lowest therapeutic dose has not yet established itself. For a thorough look at how the Wegovy dosage schedule works from start to maintenance, that is worth reading before your first prescription.

Clinically, the 68-week STEP 1 trial (the pivotal study published in the New England Journal of Medicine that supported Wegovy's UK licence) showed approximately 15% average body-weight reduction at the 2.4 mg maintenance dose. That figure is the product of the full treatment course, titration included, alongside a reduced-calorie diet and increased physical activity. It is not a projection from week one.

Why the dose escalation matters more than most people realise

The titration schedule (0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, then 2.4 mg, each step held for around four weeks before the prescriber moves you up) is not bureaucratic delay. Each step serves a purpose. Jumping ahead would not speed up weight loss in any meaningful way; it would most likely produce more severe side effects, which is the most common reason people stop a medicine that was otherwise working.

The MHRA-approved higher dose, 7.2 mg (approved January 2026 and in dedicated single-dose pen form from April 2026), follows the same principle: patients still begin at 0.25 mg and escalate through the same steps. The destination is different; the runway to get there is not. You can read more about the full Wegovy dosage progression if you are at an earlier stage of the process.

One practical detail worth knowing: if your first prescription arrives mid-week, or you start the week before a holiday, the four-week rhythm of dose reviews means timing compounds. A few people find it helps to pick a consistent day of the week for injections, Monday works well for many because it is easy to remember and repeat orders tend to land before the weekend. That kind of simple structure matters more over a year of weekly injections than it might feel like it does at the start.

For a broader look at Wegovy dose strengths and how they are used, that page covers each stage in more detail. And if you are weighing up the cost side of a longer treatment course, the Wegovy price breakdown explains what private treatment typically costs at each dose.

When to talk to your prescriber about the first dose not working as expected

If you reach the end of six months at the highest tolerated dose and less than 5% of your starting body weight has changed, that is a clinical signal worth discussing. NICE guidance on semaglutide (TA875) includes exactly this checkpoint, it is not a personal failing; it is a decision point baked into the clinical pathway. Some people respond more strongly than others, and that is a conversation for a prescriber, not something to troubleshoot alone.

Separately, if your side effects feel severe enough to interfere with daily life, that too is a reason to contact your clinical team rather than simply push through. The page on the first dose not working as expected goes into both scenarios in more detail. You can also read about what to expect from the first dose of semaglutide across the broader class of medicines, not just Wegovy specifically.

Wegovy is a prescription-only medicine. A prescriber decides whether it is suitable for you and at what pace to increase your dose. If you are exploring whether treatment might be right for you, our clinical team reviews consultations the same day they are submitted. Check your eligibility and a real prescriber, not an algorithm, will go through it with you.